BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 9841929)

  • 1. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells.
    Inaba K; Turley S; Yamaide F; Iyoda T; Mahnke K; Inaba M; Pack M; Subklewe M; Sauter B; Sheff D; Albert M; Bhardwaj N; Mellman I; Steinman RM
    J Exp Med; 1998 Dec; 188(11):2163-73. PubMed ID: 9841929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
    Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
    J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes.
    Inaba K; Pack M; Inaba M; Sakuta H; Isdell F; Steinman RM
    J Exp Med; 1997 Aug; 186(5):665-72. PubMed ID: 9271582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.
    Bozzacco L; Yu H; Zebroski HA; Dengjel J; Deng H; Mojsov S; Steinman RM
    J Proteome Res; 2011 Nov; 10(11):5016-30. PubMed ID: 21913724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis.
    Wilson NS; El-Sukkari D; Villadangos JA
    Blood; 2004 Mar; 103(6):2187-95. PubMed ID: 14604956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
    Chen Z; Moyana T; Saxena A; Warrington R; Jia Z; Xiang J
    Int J Cancer; 2001 Aug; 93(4):539-48. PubMed ID: 11477558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trogocytosis of peptide-MHC class II complexes from dendritic cells confers antigen-presenting ability on basophils.
    Miyake K; Shiozawa N; Nagao T; Yoshikawa S; Yamanishi Y; Karasuyama H
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1111-1116. PubMed ID: 28096423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.
    Villadangos JA; Schnorrer P; Wilson NS
    Immunol Rev; 2005 Oct; 207():191-205. PubMed ID: 16181337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and phenotypic evidence for presentation of E alpha 52-68 structurally related self-peptide(s) in I-E alpha-deficient mice.
    Viret C; Janeway CA
    J Immunol; 2000 May; 164(9):4627-34. PubMed ID: 10779766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells.
    MuixĂ­ L; Contreras V; Collado JA; Alexandre Y; Ballingall K; Bonneau M; Jaraquemada D; Schwartz-Cornil I
    Int Immunol; 2012 Jan; 24(1):59-69. PubMed ID: 22194283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
    Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
    J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
    Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
    J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
    Zhong G; Reis e Sousa C; Germain RN
    J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation.
    Delamarre L; Holcombe H; Mellman I
    J Exp Med; 2003 Jul; 198(1):111-22. PubMed ID: 12835477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.
    Kamphorst AO; Guermonprez P; Dudziak D; Nussenzweig MC
    J Immunol; 2010 Sep; 185(6):3426-35. PubMed ID: 20729332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.